The Value of Amniopatch in Preterm Premature Rupture of Membranes
Status:
Completed
Trial end date:
2018-03-11
Target enrollment:
Participant gender:
Summary
A randomized controlled trial that involved 100 women diagnosed with PPROM between 24 and 34
weeks of gestational age. Participants were randomized equally into 2 groups. Group I in
which amniopatch was done (an amnioinfusion of platelet concentrate followed by fresh frozen
plasma in addition to the routine management used in the control group. Group II were treated
with routine management including antibiotics and corticosteroids